Inventor
Marc E. Rothenberg
Inventor
Cincinnati, OH, US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms22%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
C12NMicroorganisms or enzymes10%
C07KPeptides8%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
Y02ATechnologies for adaptation to climate change6%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology4%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data4%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients2%
PatentTitleYear
10,821,094Compositions and methods for treating allergic inflammatory conditions202010,435,452Cadherin 26 (CDH26)-Fc fusion proteins and methods of use thereof to treat inflammatory conditions201910,422,004Diagnostic method for distinguishing forms of esophageal eosinophilia201910,294,517Genetic test for determining susceptibility for eosinophilic esophagitis201910,155,985Evaluation of eosinophilic esophagitis20189,982,303Determination of eosinophilic esophagitis20189,928,344'Diagnostic methods of eosinophilic esophagitis'20189,803,244'Methods of determining eosinophilic gastritis status based on marker or gene expression'20179,624,545'Esophageal microRNA expression profiles in eosinophilic esophagitis'20179,517,238'Compositions and methods for treating allergic inflammation through inhibition of NTRK1'20169,345,763'Methods of treating allergic inflammatory conditions by administering an anti-cadherin-like 26-based therapeutic'20168,409,565'Therapeutic target and diagnostic marker for asthma and related conditions'20138,030,003'Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3'20117,879,547'Method of detecting the presence of asthma or allergies in a patient'20116,358,697'Intracellular pharmaceutical targeting'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2016Patents assigned to CHILDRENS HOSP MEDICAL CENTER (4)· patent assignee history
2002–2020Based in Cincinnati, OH, US· patent location history
2013–2018Patents assigned to ROTHENBERG MARC E (3)· patent assignee history
2013Patents assigned to BACHELET IDO (1)· patent assignee history
2016–2017Patents assigned to CHILDREN'S HOSPITAL MEDICAL CENTER (3)· patent assignee history
2018–2020Patents assigned to CHILDRENS HOSPITAL MED CT (7)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHILDRENS HOSPITAL MED CT | 7 | 2018–2020 |
| CHILDRENS HOSP MEDICAL CENTER | 4 | 2002–2016 |
| CHILDREN'S HOSPITAL MEDICAL CENTER | 3 | 2016–2017 |
| ROTHENBERG MARC Eself | 3 | 2013–2018 |
| BACHELET IDO | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cincinnati, OH, US | 15 | 2002–2020 |